Skip to main content
SpringerLink
Log in

An Overview of the Extent and Nature of Menopause and Its Physiological Basis

  • Chapter
  • First Online:
Nutrition and Diet in Menopause

Part of the book series: Nutrition and Health ((NH))

  • 2733 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

FMP:

Final menstrual period

STRAW:

Stages of reproductive aging workshop

LH:

Luteinizing hormone

FSH:

Follicle-stimulating hormone

GnRH:

Gonadotrophin-releasing hormone

VMS:

Vasomotor menopausal symptoms

CVD:

Cardiovascular diseases

CHD:

Coronary heart disease

HT:

Hormone therapy

HERS:

Heart and estrogen/progestin replacement study

WHI:

Women’s Health Initiative trial

BMD:

Bone mineral density

References

  1. WHO Scientific Group on Research on the Menopause in the 1990s. Geneva, WHO: WHO Technical report series, Research on the menopause in the 1990s; 1996. Ref Type: Report. 866.

    Google Scholar 

  2. Peccei JS. A critique of the grandmother hypotheses: old and new. Am J Hum Biol. 2001;13:434–52.

    Article  PubMed  CAS  Google Scholar 

  3. Hawkes K, O’Connell JF, Jones NG, Alvarez H, Charnov EL. Grandmothering, menopause, and the evolution of human life histories. Proc Natl Acad Sci USA. 1998;95:1336–9.

    Article  PubMed  CAS  Google Scholar 

  4. Kirkwood TB. Evolution of ageing. Nature. 1977;270:301–4.

    Article  PubMed  CAS  Google Scholar 

  5. Walker ML, Herndon JG. Menopause in nonhuman primates? Biol Reprod. 2008;79:398–406.

    Article  PubMed  CAS  Google Scholar 

  6. Walker ML, Anderson DC, Herndon JG, Walker LC. Ovarian aging in squirrel monkeys (Saimiri sciureus). Reproduction. 2009;138:793–9.

    Article  PubMed  CAS  Google Scholar 

  7. Treloar AE, Boynton RE, Behn BG. Variation of the human menstrual cycle through reproductive life. Int J Fertil. 1967;12:77–126.

    PubMed  CAS  Google Scholar 

  8. Treloar AE. Menstrual cyclicity and the pre-menopause. Maturitas. 1981;3:249–64.

    Article  PubMed  CAS  Google Scholar 

  9. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al. Executive summary of the stages of reproductive aging workshop  +  10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387–95.

    Article  PubMed  Google Scholar 

  10. Baker TG. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond B Biol Sci. 1963;158:417–33.

    Article  PubMed  CAS  Google Scholar 

  11. Block E. Quantitative morphological investigations of the follicular system in women; variations at different ages. Acta Anat (Basel). 1952;14:108–23.

    Article  CAS  Google Scholar 

  12. Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab. 1987;65:1231–7.

    Article  PubMed  CAS  Google Scholar 

  13. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992;7:1342–6.

    PubMed  CAS  Google Scholar 

  14. Morabia A, Costanza MC. International variability in ages at menarche, first livebirth, and menopause. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Am J Epidemiol. 1998;148:1195–205.

    Article  PubMed  CAS  Google Scholar 

  15. Noord-Zaadstra BM, Looman CW, Alsbach H, Habbema JD, te Velde ER, Karbaat J. Delaying childbearing: effect of age on fecundity and outcome of pregnancy. BMJ. 1991;302:1361–5.

    Article  PubMed  Google Scholar 

  16. Burger HG, Hale GE, Dennerstein L, Robertson DM. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause. 2008;15:603–12.

    Article  PubMed  Google Scholar 

  17. Burger H. The menopausal transition—endocrinology. J Sex Med. 2008;5:2266–73.

    PubMed  CAS  Google Scholar 

  18. Burger HG, Dudley EC, Hopper JL, Shelley JM, Green A, Smith A, et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab. 1995;80:3537–45.

    Article  PubMed  CAS  Google Scholar 

  19. Burger HG, Cahir N, Robertson DM, Groome NP, Dudley E, Green A, et al. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol (Oxf). 1998;48:809–13.

    Article  CAS  Google Scholar 

  20. Welt CK, Adams JM, Sluss PM, Hall JE. Inhibin A and inhibin B responses to gonadotropin withdrawal depends on stage of follicle development. J Clin Endocrinol Metab. 1999;84:2163–9.

    Article  PubMed  CAS  Google Scholar 

  21. Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women’s Midlife Health Project. Hum Reprod Update. 2007;13:559–65.

    Article  PubMed  CAS  Google Scholar 

  22. Sowers MR, Zheng H, McConnell D, Nan B, Harlow SD, Randolph Jr JF. Estradiol rates of change in relation to the final menstrual period in a population-based cohort of women. J Clin Endocrinol Metab. 2008;93:3847–52.

    Article  PubMed  CAS  Google Scholar 

  23. Backman G. Die beschleunigte Entwicklung der Jugend. Verfrühte Menarche, verspätete Menopause, verlängerte Lebensdauer. Acta Anat (Basel). 1947;4:421–80.

    Article  Google Scholar 

  24. Tanner JM. Growth at adolescence: with a general consideration of the effects of hereditary and environmental factors upon growth and maturation from birth to maturity. Oxford: Blackwell Scientific Publications; 1962.

    Google Scholar 

  25. Amundsen DW, Diers CJ. The age of menopause in classical Greece and Rome. Hum Biol. 1970;42:79–86.

    PubMed  CAS  Google Scholar 

  26. Amundsen DW, Diers CJ. The age of menopause in medieval Europe. Hum Biol. 1973;45:605–12.

    PubMed  CAS  Google Scholar 

  27. Treloar AE. Menarche, menopause, and intervening fecundability. Hum Biol. 1974;46:89–107.

    PubMed  CAS  Google Scholar 

  28. Flint M. Is there a secular trend in age of menopause? Maturitas. 1978;1:133–9.

    Article  PubMed  CAS  Google Scholar 

  29. Flint MP. Secular trends in menopause age. J Psychosom Obstet Gynaecol. 1997;18:65–72.

    Article  PubMed  CAS  Google Scholar 

  30. Frommer J. Changing age of the menopause. Br Med J. 1964;2:349–51.

    Article  PubMed  CAS  Google Scholar 

  31. MacMahon B, Worcester J. Age at menopause, United States 1960–62. US Dept of Health, Education and Welfare, Public Health Service, National Center for Health Statistics, Series 11, Number 19. Washington, DC: US Government Printing Office; 1966.

    Google Scholar 

  32. McKinlay S, Jefferys M, Thompson B. An investigation of the age at menopause. J Biosoc Sci. 1972;4:161–73.

    Article  PubMed  CAS  Google Scholar 

  33. van Asselt KM, Kok HS, van der Schouw YT, Grobbee DE, te Velde ER, Pearson PL, et al. Current smoking at menopause rather than duration determines the onset of natural menopause. Epidemiology. 2004;15:634–9.

    Article  PubMed  Google Scholar 

  34. McKinlay SM, Bifano NL, McKinlay JB. Smoking and age at menopause in women. Ann Intern Med. 1985;103:350–6.

    Article  PubMed  CAS  Google Scholar 

  35. Rodstrom K, Bengtsson C, Milsom I, Lissner L, Sundh V, Bjourkelund C. Evidence for a secular trend in menopausal age: a population study of women in Gothenburg. Menopause. 2003;10:538–43.

    Article  PubMed  Google Scholar 

  36. Nichols HB, Trentham-Dietz A, Hampton JM, et al. From menarche to menopause: trends among US Women born from 1912 to 1969. Am J Epidemiol. 2006;164:1003–11.

    Article  PubMed  Google Scholar 

  37. Kalichman L, Malkin I, Kobyliansky E. Time-related trends of age at menopause and reproductive period of women in a Chuvashian rural population. Menopause. 2007;14:135–40.

    Article  PubMed  Google Scholar 

  38. Dratva J, Gomez Real F, Schindler C, Ackermann-Liebrich U, Gerbase MW, Probst-Hensch NM, et al. Is age at menopause increasing across Europe? Results on age at menopause and determinants from two population-based studies. Menopause. 2009;16:385–94.

    Article  PubMed  Google Scholar 

  39. Pakarinen M, Raitanen J, Kaaja R, Luoto R. Secular trend in the menopausal age in Finland 1997–2007 and correlation with socioeconomic, reproductive and lifestyle factors. Maturitas. 2010;66:417–22.

    Article  PubMed  Google Scholar 

  40. Stearns V, Ullmer L, Lopez JF, Smith Y, Isaacs C, Hayes D. Hot flushes. Lancet. 2002;360:1851–61.

    Article  PubMed  CAS  Google Scholar 

  41. Freedman RR. Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med. 2005;23:117–25.

    Article  PubMed  Google Scholar 

  42. Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci. 1990;592:52–86.

    Article  PubMed  CAS  Google Scholar 

  43. Freedman RR, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol. 1999;181:66–70.

    Article  PubMed  CAS  Google Scholar 

  44. Savage MV, Brengelmann GL. Control of skin blood flow in the neutral zone of human body temperature regulation. J Appl Physiol. 1996;80:1249–57.

    PubMed  CAS  Google Scholar 

  45. Freedman RR. Physiology of hot flashes. Am J Hum Biol. 2001;13:453–64.

    Article  PubMed  CAS  Google Scholar 

  46. Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA. 2004;291:1610–20.

    Article  PubMed  CAS  Google Scholar 

  47. Gast GC, Samsioe G, Grobbee DE, Nilsson PM, van der Schouw YT. Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women. Maturitas. 2010;66:285–90.

    Article  PubMed  CAS  Google Scholar 

  48. Deecher DC, Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Arch Womens Ment Health. 2007;10:247–57.

    Article  PubMed  CAS  Google Scholar 

  49. Freeman EW, Sammel MD, Lin H, et al. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol. 2007;110:230–40.

    Article  PubMed  Google Scholar 

  50. Politi MC, Schleinitz MD, Col NF. Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med. 2008;23:1507–13.

    Article  PubMed  Google Scholar 

  51. McKinlay SM, Jefferys M. The menopausal syndrome. Br J Prev Soc Med. 1974;28:108–15.

    PubMed  CAS  Google Scholar 

  52. Freeman EW, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric. 2007;10:197–214.

    Article  PubMed  CAS  Google Scholar 

  53. Huang AJ, Grady D, Jacoby VL, Blackwell TL, Bauer DC, Sawaya GF. Persistent hot flushes in older postmenopausal women. Arch Intern Med. 2008;168:840–6.

    Article  PubMed  Google Scholar 

  54. Bachmann GA. Vasomotor flushes in menopausal women. Am J Obstet Gynecol. 1999;180:S312–6.

    Article  PubMed  CAS  Google Scholar 

  55. Nelson HD. Menopause. Lancet. 2008;371:760–70.

    Article  PubMed  Google Scholar 

  56. Avis NE, Brockwell S, Colvin A. A universal menopausal syndrome? Am J Med. 2005;118(Suppl 12B):37–46.

    Article  PubMed  Google Scholar 

  57. Greendale GA, Lee NP, Arriola ER. The menopause. Lancet. 1999;353:571–80.

    Article  PubMed  CAS  Google Scholar 

  58. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;96:351–8.

    Article  PubMed  CAS  Google Scholar 

  59. Avis NE, Brambilla D, McKinlay SM, Vass K. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women’s Health Study. Ann Epidemiol. 1994;4:214–20.

    Article  PubMed  CAS  Google Scholar 

  60. Hunter MS. Psychological and somatic experience of the menopause: a prospective study [corrected]. Psychosom Med. 1990;52:357–67.

    PubMed  CAS  Google Scholar 

  61. Witteman JC, Moerman CJ, Westendorp IC. Myth of the menopause paradox. Lancet. 1998;352:407.

    Article  PubMed  CAS  Google Scholar 

  62. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and the risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976;85:447–52.

    Article  PubMed  CAS  Google Scholar 

  63. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105–10.

    Article  PubMed  CAS  Google Scholar 

  64. Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause. 2009;16:15–23.

    Article  PubMed  Google Scholar 

  65. Parker WH, Jacoby V, Shoupe D, Rocca W. Effect of bilateral oophorectomy on women’s long-term health. Womens Health (Lond Engl). 2009;5:565–76.

    Article  Google Scholar 

  66. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 1996;347:714–8.

    Article  PubMed  Google Scholar 

  67. de Kleijn MJ, van der Schouw YT, Verbeek AL, Peeters PH, Banga JD, van der Graaf Y. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol. 2002;155:339–45.

    Article  PubMed  Google Scholar 

  68. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006;13:265–79.

    Article  PubMed  Google Scholar 

  69. Baer HJ, Glynn RJ, Hu FB, Hankinson SE, Willett WC, Colditz GA, et al. Risk factors for mortality in the nurses’ health study: a competing risks analysis. Am J Epidemiol. 2011;173:319–29.

    Article  PubMed  Google Scholar 

  70. Bairey Merz CN, Johnson BD, Sharaf BL, Bittner V, Berga SL, Braunstein GD, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol. 2003;41:413–9.

    Article  PubMed  CAS  Google Scholar 

  71. Barrett-Connor E, Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ. 1995;311:1193–6.

    Article  PubMed  CAS  Google Scholar 

  72. Rexrode KM, Manson JE, Lee IM, et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation. 2003;108(14):1688–93.

    Article  PubMed  CAS  Google Scholar 

  73. Chen Y, Zeleniuch-Jacquotte A, Arslan AA, Wojcik O, Toniolo P, Shore RE, et al. Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis. 2011;216:414–9.

    Article  PubMed  CAS  Google Scholar 

  74. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47–63.

    Article  PubMed  CAS  Google Scholar 

  75. Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis. 1995;38:199–210.

    Article  PubMed  CAS  Google Scholar 

  76. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 2000;133:933–41.

    Article  PubMed  CAS  Google Scholar 

  77. Grodstein F, Manson JE, Stampfer MJ. Postmenopausal hormone use and secondary prevention of coronary events in the nurses’ health study. a prospective, observational study. Ann Intern Med. 2001;135:1–8.

    Article  PubMed  CAS  Google Scholar 

  78. Farquhar C, Marjoribanks J, Lethaby A, Suckling JA, Lamberts Q. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2009;CD004143.

    Google Scholar 

  79. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465–77.

    Article  PubMed  CAS  Google Scholar 

  80. Lindh-Astrand L, Brynhildsen J, Hoffman M, Hammar M. Vasomotor symptoms usually reappear after cessation of postmenopausal hormone therapy: a Swedish population-based study. Menopause. 2009;16(6):1213–7.

    Article  PubMed  Google Scholar 

  81. Burger HG. WHI risks: any relevance to menopause management? Maturitas. 2007;57:6–10.

    Article  PubMed  CAS  Google Scholar 

  82. van der Schouw YT, Grobbee DE. Menopausal complaints, oestrogens, and heart disease risk: an explanation for discrepant findings on the benefits of post-menopausal hormone therapy. Eur Heart J. 2005;26:1358–61.

    Article  PubMed  CAS  Google Scholar 

  83. Gast GC, Grobbee DE, Pop VJ, Keyzer JJ, Wijnands-van Gent CJ, Samsioe GN, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension. 2008;51:1492–8.

    Article  PubMed  CAS  Google Scholar 

  84. Gast GC, Pop VJ, Samsioe G, Grobbee DE, Nilsson PM, Keyzer JJ, et al. Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease. Menopause. 2011;18:51.

    Google Scholar 

  85. Tuomikoski P, Mikkola TS, Hamalainen E, Tikkanen MJ, Turpeinen U, Ylikorkala O. Biochemical markers for cardiovascular disease in recently postmenopausal women with or without hot flashes. Menopause. 2010;17:151.

    Article  Google Scholar 

  86. Svartberg J, von MD, Kritz-Silverstein D, Barrett-Connor E. Vasomotor symptoms and mortality: the Rancho Bernardo Study. Menopause. 2009;16:888–91.

    Article  PubMed  Google Scholar 

  87. Allison MA, Manson JE, Aragaki A, et al. Vasomotor symptoms and coronary artery calcium in postmenopausal women. Menopause. 2010;17:1145.

    Article  Google Scholar 

  88. Allison MA, Manson JE. The complex interplay of vasomotor symptoms, hormone therapy, and cardiovascular risk. Menopause. 2009;16:619–20.

    Article  PubMed  Google Scholar 

  89. Gast GC, Pop VJ, Samsioe GN, Grobbee DE, Nilsson PM, Keyzer JJ, et al. Hormone therapy and coronary heart disease risk by vasomotor menopausal symptoms. Maturitas. 2011;70:373–8.

    Article  PubMed  CAS  Google Scholar 

  90. Block JE, Smith R, Glueer CC, Steiger P, Ettinger B, Genant HK. Models of spinal trabecular bone loss as determined by quantitative computed tomography. J Bone Miner Res. 1989;4:249–57.

    Article  PubMed  CAS  Google Scholar 

  91. Gudmundsdottir H, Jonsdottir B, Kristinsson S, Johannesson A, Goodenough D, Sigurdsson G. Vertebral bone density in Icelandic women using quantitative computed tomography without an external reference phantom. Osteoporos Int. 1993;3:84–9.

    Article  PubMed  CAS  Google Scholar 

  92. Seifert-Klauss V, Link T, Heumann C, Luppa P, Haseitl M, Laakmann J, et al. Influence of pattern of menopausal transition on the amount of trabecular bone loss. Results from a 6-year prospective longitudinal study. Maturitas. 2006;55:317–24.

    Article  PubMed  CAS  Google Scholar 

  93. Prior JC, Vigna YM, Wark JD, Eyre DR, Lentle BC, Li DK, et al. Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate. J Bone Miner Res. 1997;12:1851–63.

    Article  PubMed  CAS  Google Scholar 

  94. Genant HK, Cann CE, Ettinger B, Gordan GS. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med. 1982;97:699–705.

    Article  PubMed  CAS  Google Scholar 

  95. Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause. 2007;14:567–71.

    Article  PubMed  Google Scholar 

  96. Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med. 1980;303:1195–8.

    Article  PubMed  CAS  Google Scholar 

  97. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016–37.

    Article  PubMed  CAS  Google Scholar 

  98. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1995;122:9–16.

    Article  PubMed  CAS  Google Scholar 

  99. Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N, et al. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev. 2002;23:529–39.

    Article  PubMed  CAS  Google Scholar 

  100. Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA. 2001;285:2891–7.

    Article  PubMed  CAS  Google Scholar 

  101. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy: scientific review. JAMA. 2002;288:872–81.

    Article  PubMed  CAS  Google Scholar 

  102. Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R, et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008;299:1036–45.

    Article  PubMed  CAS  Google Scholar 

  103. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. “Hormonal” risk factors, “breast tissue age” and the age-incidence of breast cancer. Nature. 1983;303:767–70.

    Article  PubMed  CAS  Google Scholar 

  104. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet. 1997;350:1047–59.

    Google Scholar 

  105. Persson I. Estrogens in the causation of breast, endometrial and ovarian cancers—evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol. 2000;74:357–64.

    Article  PubMed  CAS  Google Scholar 

  106. Klinkert ER. Clinical significance and management of poor response in IVF. Ref Type: Thesis/Dissertation: Utrecht University; 2005.

    Google Scholar 

  107. Lambalk CB, van Disseldorp J, de Koning CH, Broekmans FJ. Testing ovarian reserve to predict age at menopause. Maturitas. 2009;63:280–91.

    Article  PubMed  CAS  Google Scholar 

  108. Ferrell RJ, Sowers M. Longitudinal, epidemiologic studies of female reproductive aging. Ann N Y Acad Sci. 2010;1204:188–97.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, STR 6.131, 85500, Utrecht, 3508 GA, The Netherlands

    Yvonne T. van der Schouw Ph.D.

Authors
  1. Yvonne T. van der Schouw Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yvonne T. van der Schouw Ph.D. .

Editor information

Editors and Affiliations

  1. School of Nursing, Midwifery and Social, College of Health and Social Care, Department of Midwifery, University of Salford, Salford, M5 4WT, United Kingdom

    Caroline J. Hollins Martin

  2. Mel and Enid Zuckerman College of Public, Health, and School of Medicine, University of Arizona, Arizona Health Sciences Center, Tucson, 85724-5155, Arizona, USA

    Ronald Ross Watson

  3. Dept. Nutrition & Dietetics, King's College, Stamford St. 150, London, SE1 9NH, United Kingdom

    Victor R. Preedy

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

van der Schouw, Y.T. (2013). An Overview of the Extent and Nature of Menopause and Its Physiological Basis. In: Hollins Martin, C., Watson, R., Preedy, V. (eds) Nutrition and Diet in Menopause. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-373-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-373-2_1

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-372-5

  • Online ISBN: 978-1-62703-373-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation